A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNFα Naive Participants With Active Radiographic Axial Spondyloarthritis
Clinical trial NCT02437162 · TERMINATED
Trial details
- NCT number
- NCT02437162
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-03
- Primary completion
- 2017-03-22
- Enrollment
- 347
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.